Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial β-glucuronidase
Irinotecan (CPT11), a broad-spectrum cytotoxic anticancer agent, induces a series of toxic side-effects. The most conspicuous side-effect is gastrointestinal mucositis, including nausea, vomiting, and diarrhea. A growing body of evidence indicates that bacteria β-glucuronidase (GUS), an enzyme expre...
Saved in:
Main Authors: | Bei Yue (Author), Ruiyang Gao (Author), Cheng Lv (Author), Zhilun Yu (Author), Hao Wang (Author), Xiaolong Geng (Author), Zhengtao Wang (Author), Wei Dou (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Carvone Attenuates Irinotecan-Induced Intestinal Mucositis and Diarrhea in Mice
by: Ban Walid Abbas, et al.
Published: (2021) -
Systematic evaluation of irinotecan-induced intestinal mucositis based on metabolomics analysis
by: Qing-Qing Yu, et al.
Published: (2022) -
The effective combination therapies with irinotecan for colorectal cancer
by: Yun Chai, et al.
Published: (2024) -
IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2008) -
CAPECITABINE AND IRINOTECAN AS FIRST- LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2010)